The chromomycin CmmA acetyltransferase: A membrane-bound enzyme as a tool for increasing structural diversity of the antitumour mithramycin

Microbial Biotechnology

Volumn 4, Issue 2, 2011, Pages 226-238

  García, Beatriz ^a   González Sabín, Javier ^b   Menéndez, Nuria ^a   Brana, Alfredo F ^a   Nunez, Luz Elena ^b   Morís, Francisco ^b   Salas, José A ^a   Méndez, Carmen ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b EntreChem SL Edificio Científico Tecnológico ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CHROMOMYCIN; MEMBRANE ENZYME; MITHRAMYCIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOTRANSFORMATION; CANCER CELL CULTURE; CELL FRACTIONATION; CELL MEMBRANE; COLON TUMOR; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; GLIOBLASTOMA; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PANCREAS TUMOR; TUMOR CELL;

ACETYLTRANSFERASES; ANTINEOPLASTIC AGENTS; BACTERIAL PROTEINS; BIOTRANSFORMATION; CELL LINE, TUMOR; CELL MEMBRANE; CHROMOMYCINS; HUMANS; PLICAMYCIN; STREPTOMYCES GRISEUS;

STREPTOMYCES GRISEUS;

EID: 79951815138     PISSN: 17517907     EISSN: 17517915     Source Type: Journal    
DOI: 10.1111/j.1751-7915.2010.00229.x     Document Type: Article

References (42)

1. Albertini, V., Jain, A., Vignati, S., Napoli, S., Rinaldi, A., Kwee, I., etal. (2006) Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy. Nucleic Acids Res 34: 1721-1734.
2. Arisawa, A., Kawamura, N., Takeda, K., Tsunekawa, H., Okamura, K., and Okamoto, R. (1994) Cloning of the macrolide antibiotic biosynthesis gene acyA, which encodes 3-O-acyltransferase, from Streptomyces thermotolerans and its use for direct fermentative production of a hybrid macrolide antibiotic. Appl Environ Microbiol 60: 2657-2660.
3. Baig, I., Perez, M., Braña, A.F., Gomathinayagam, R., Damodaran, C., Salas, J.A., etal. (2008) Mithramycin analogues generated by combinatorial biosynthesis show improved bioactivity. J Nat Prod 71: 199-207.
4. Barcelo, F., Scotta, C., Ortiz-Lombardía, M., Méndez, C., Salas, J.A., and Portugal, J. (2007) Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequences. Nucleic Acids Res 35: 2215-2226.
5. Blume, S.W., Snyder, R.C., Ray, R., Thomas, S., Koller, C.A., and Miller, D.M. (1991) Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest 88: 1613-1621.
6. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
7. Burnette, W.N. (1981) 'Western blotting': electrophoretic transfer of proteins from sodium dodecyl sulphate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 112: 195-203.
8. Chakrabarti, S., Bhattacharyya, D., and Dasgupta, D. (2001) Structural basis of DNA recognition by anticancer antibiotics, chromomycin A(3), and mithramycin: roles of minor groove width and ligand flexibility. Biopolymers 56: 85-95.
9. Chatterjee, S., Zaman, K., Ryu, H., Conforto, A., and Ratan, R.R. (2001) Sequence-selective DNA binding drugs mithramycin A and chromomycin A3 are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neurons. Ann Neurol 49: 345-354.
10. Chua, Y.J., and Zalcberg, J.R. (2008) Pancreatic cancer - is the wall crumbling? Ann Oncol 19: 1224-1230.
11. Ertel, A., Verghese, A., Byers, S.W., Ochs, M., and Tozeren, A. (2006) Pathway-specific differences between tumor cell lines and normal and tumor tissue cells. Mol Cancer 5: 55.
12. Fernández, E., Weibbach, U., Sánchez Reillo, C., Braña, A.F., Méndez, C., Rohr, J., and Salas, J.A. (1998) Identification of two genes from Streptomyces argillaceus encoding two glycosyltransferases involved in the transfer of a disaccharide during the biosynthesis of the antitumor drug mithramycin. J Bacteriol 180: 4929-4937.
13. Fibach, E., Bianchi, N., Borgatti, M., Prus, E., and Gambari, R. (2003) Mithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cells. Blood 102: 1276-1281.
14. Hara, O., and Hutchinson, C.R. (1992) A macrolide 3-O-acyltransferase gene from the midecamycin-producing species Streptomyces mycarofaciens. J Bacteriol 174: 5141-5144.
15. Jia, Z., Zhang, J., Wei, D., Wang, L., Yuan, P., Le, X., etal. (2007) Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A. Cancer Res 67: 4878-4885.
16. Kieser, T., Bibb, M.J., Buttner, M.J., Chater, K.F., and Hopwood, D.A. (2000) Practical Streptomyces Genetics. Norwich, UK: The John Innes Foundation.
17. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
18. 2+ complexes of chromomycin A3 and mithramycin with poly(dG-dC)×poly(dC-dG) and poly(dG)×poly(dC). Biochemistry 36: 2291-2299.
19. 3 in Streptomyces griseus: analysis of the gene cluster and rational design of novel chromomycin analogues. Chem Biol 11: 21-32.
20. 3 by Streptomyces griseus subsp. griseus. Mol Microbiol 53: 903-915.
21. 3 biosynthesis in Streptomyces griseus subsp. griseus: new derivatives with antitumor activity. Appl Environ Microbiol 72: 67-77.
22. Menéndez, N., Braña, A.F., Salas, J.A., and Méndez, C. (2007) Involvement of a chromomycin ABC transporter system in secretion of a deacetylated precursor during chromomycin biosynthesis. Microbiology 153: 3061-3070.
23. Miller, D.M., Polansky, D.A., Thomas, S.D., Ray, R., Campbell, V.W., Sanchez, J., and Koller, C.A. (1987) Mithramycin selectively inhibits transcription of G-C containing DNA. Am J Med Sci 294: 388-394.
24. Mir, M.A., Majee, S., Das, S., and Dasgupta, D. (2003) Association of chromatin with anticancer antibiotics, mithramycin and chromomycin A3. Bioorg Med Chem 11: 2791-2801.
25. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay. J Immunol Methods 65: 55-63.
26. Moss, S.J., Bai, L., Toelzer, S., Carroll, B.J., Mahmud, T., Yu, T.W., and Floss, H.G. (2002) Identification of asm19 as an acyltransferase attaching the biologically essential ester side chain of ansamitocins using N-desmethyl-4, 5-desepoxymaytansinol, not maytansinol, as its substrate. J Am Chem Soc 124: 6544-6545.
27. Newman, J., and Cragg, G.M. (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70: 461-477.
28. Olano, C., Gómez, C., Pérez, M., Palomino, M., Pineda-Lucena, A., Carbajo, R.J., etal. (2009) Deciphering biosynthesis of the RNA polymerase inhibitor streptolydigin and generation of glycosylated derivatives. Chem Biol 16: 1031-1044.
29. Pérez, M., Baig, I., Braña, A.F., Salas, J.A., Rohr, J., and Méndez, C. (2008) Generation of new derivatives of the antitumor antibiotic mithramycin by altering the glycosylation pattern through combinatorial biosynthesis. Chembiochem 9: 2295-2304.
30. Ray, R., Snyder, R.C., Thomas, S., Koller, C.A., and Miller, D.M. (1989) Mithramycin blocks protein binding and function of the SV40 early promoter. J Clin Invest 83: 2003-2007.
31. Remers, W.A. (1979) The Chemistry of Antitumor Antibiotics, Vol. 1. New York, USA: Wiley-Interscience.
32. Remsing, L.L., González, A.M., Nur-e-Alam, M., Fernández-Lozano, M.J., Braña, A.F., Rix, U., etal. (2003) Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosyl-mithramycin SK: three new products generated in the mithramycin producer Streptomyces argillaceus through combinatorial biosynthesis. J Am Chem Soc 125: 5745-5753.
33. Rohr, J., Méndez, C., and Salas, J.A. (1999) The biosynthesis of aureolic acid group antibiotics. Bioorg Chem 27: 41-54.
34. Sambrook, J., and Russell, D.W. (2001) Molecular Cloning: A Laboratory Manual, 3rd edn. Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory.
35. Sastry, M., and Patel, D.J. (1993) Solution structure of the mithramycin dimer-DNA complex. Biochemistry 32: 6588-6604.
36. Sastry, M., Fiala, R., and Patel, D.J. (1995) Solution structure of mithramycin dimers bound to partially overlapping sites on DNA. J Mol Biol 251: 674-689.
37. Shrieve, D.C., Alexander, E., 3rd, Black, P.M., Wen, P.Y., Fine, H.A., Kooy, H.M., and Loeffler, J.S. (1999) Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg 90: 72-77.
38. Silva, D.J., and Kahne, D.E. (1993) Studies of the 2:1 chromomycin A3-Mg2+ complex in methanol: role of the carbohydrates in complex formation. J Am Chem Soc 115: 7962-7970.
39. 3 stabilize the Mg(2+)-dimer complex. Biochemistry 32: 463-471.
40. Skarbek, J.D., and Speedie, M.K. (1981) Antitumor antibiotics of the aureolic acid group: chromomycin A3, mithramycin A, and olivomycin A. In Antitumor Compounds of Natural Origin, Vol. 1. Aszalos, A. (ed.). Boca Raton, FL, USA: CRC Press, pp. 191-235.
41. Snyder, R.C., Ray, R., Blume, S., and Miller, D.M. (1991) Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. Biochemistry 30: 4290-4297.
42. Wohlert, S.E., Künzel, E., Machinek, R., Méndez, C., Salas, J.A., and Rohr, J. (1999) The structure of mithramycin reinvestigated. J Nat Prod 62: 119-121.